Longitudinal follow-up of ascending versus abdominal aortic aneurysm formation in angiotensin II-infused ApoE-/- mice

Artery Research

Volumn 8, Issue 1, 2014, Pages 16-23

  Trachet, Bram ^a,b   Renard, M ^c   Van der Donckt, C ^d   Deleye, S ^a,d   Bols, J ^a   De Meyer, G R Y ^d   Staelens, S ^a,d   Loeys, B L ^c,d   Segers, P ^a  

^a GHENT UNIVERSITY   (Belgium)

^b EPFL   (Switzerland)

^c GHENT UNIVERSITY HOSPITAL   (Belgium)

^d UNIVERSITY OF ANTWERP   (Belgium)

Author keywords

Abdominal aortic aneurysm; Angiotensin II; Ascending aortic aneurysm; High frequency ultrasound; Invivo micro CT; Mice; PET; Small animal imaging

Indexed keywords

EID: 84893906778     PISSN: 18729312     EISSN: 18764401     Source Type: Journal    
DOI: 10.1016/j.artres.2014.01.001     Document Type: Article

References (31)

1. Johnston K.W., Rutherford R.B., Tilson M.D., Shah D.M., Hollier L., Stanley J.C. Suggested standards for reporting on arterial aneurysms. Subcommittee on reporting standards for arterial aneurysms, ad hoc committee on reporting standards, society for vascular surgery and north american chapter, international society for cardiovascular surgery. J Vasc Surg 1991, 13(3):452-458.
2. Lindsay M., Dietz H.C. Lessons on the pathogenesis of aneurysm from heritable conditions. Nature 2011, 473(7347):308316.
3. Wilmink A.B., Vardulaki K.A., Hubbard C.S., Day N.E., Ashton H.A., Scott A.P., et al. Are antihypertensive drugs associated with abdominal aortic aneurysms?. J Vasc Surg 2002, 36(4):751-757.
4. Allaire E., Schneider F., Saucy F., Dai J., Cochennec F., Michineau S., et al. New insight in aetiopathogenesis of aortic diseases. Eur J Vasc Endovasc Surg 2009, 37(5):531-537.
5. Michel J., Martin-Ventura J., Egido J., Sakalihasan N., Treska V., Lindholt J., et al. Novel aspects of the pathogenesis of aneurysms of the abdominal aorta in humans. Cardiovasc Res 2011, 90(1):18-27.
6. Isselbacher E.M. Thoracic and abdominal aortic aneurysms. Circulation 2005, 111(6):816-828.
7. Alexander J.J. The pathobiology of aortic aneurysms. J Surg Res 2004, 117(1):163-175.
8. Longo G.M., Xiong W., Greiner T.C., Zhao Y., Fiotti N., Baxter B.T. Matrix metalloproteinases 2 and 9 work in concert to produce aortic aneurysms. J Clin Invest 2002, 110(5):625-632.
9. Pyo R., Lee J.K., Shipley J.M., Curci J.A., Mao D., Ziporin S.J., et al. Targeted gene disruption of matrix metalloproteinase-9 (gelatinase b) suppresses development of experimental abdominal aortic aneurysms. J Clin Invest 2000, 105(11):1641-1649.
10. Daugherty A., Manning M.W., Cassis L.A. Angiotensin ii promotes atherosclerotic lesions and aneurysms in apolipoprotein e-deficient mice. J Clin Invest 2000, 105(11):1605-1612.
11. Pereira L., Lee S.Y., Gayraud B., Andrikopoulos K., Shapiro S.D., Bunton T., et al. Pathogenetic sequence for aneurysm revealed in mice underexpressing fibrillin-1. Proc Natl Acad Sci U S A 1999, 96(7):3819-3823.
12. Habashi J.P., Judge D.P., Holm T.M., Cohn R.D., Loeys B.L., Cooper T.K., et al. Losartan, an at1 antagonist, prevents aortic aneurysm in a mouse model of marfan syndrome. Science 2006, 312(5770):117-121.
13. Ramirez F., Dietz H.C. Marfan syndrome: from molecular pathogenesis to clinical treatment. Curr Opin Genet Dev 2007, 17(3):252-258.
14. Daugherty A., Rateri D.L., Charo I.F., Owens A.P., Howatt D.A., Cassis L.A. Angiotensin ii infusion promotes ascending aortic aneurysms: attenuation by ccr2 deficiency in apoe-/- mice. Clin Science Lond Engl 1979) 2010, 118(11):681-689.
15. Saraff K., Babamusta F., Cassis L.A., Daugherty A. Aortic dissection precedes formation of aneurysms and atherosclerosis in angiotensin ii-infused, apolipoprotein e-deficient mice. Arterioscler Thromb Vasc Biol 2003, 23(9):1621-1626.
16. Barisione C., Rateri D.L., Moorleghen J.J., Howatt D.A., Daugherty A. Angiotensin ii infusion promotes rapid dilation of the abdominal aorta detected by noninvasive high frequency ultrasound. Arterioscler Thromb Vasc Biol 2006, 26(5):E73.
17. Rateri D.L., Howatt D.A., Moorleghen J.J., Charnigo R., Cassis L.A., Daugherty A. Prolonged infusion of angiotensin ii in apoe/mice promotes macrophage recruitment with continued expansion of abdominal aortic aneurysm. Am J Pathol 2011, 179(3):1542-1548.
18. Stolle K., Berges A., Lietz M., Lebrun S., Wallerath T. Cigarette smoke enhances abdominal aortic aneurysm formation in angiotensin ii-treated apolipoprotein e-deficient mice. Toxicol Lett Dec 2010, 199(3):403-409.
19. Goergen C.J., Barr K.N., Huynh D.T., Eastham-Anderson J.R., Choi G., Hedehus M., et al. Invivo quantification of murine aortic cyclic strain, motion, and curvature: implications for abdominal aortic aneurysm growth. J Magn Reson Imaging 2010, 32(4):847-858.
20. Goergen C.J., Azuma J., Barr K.N., Magdefessel L., Kallop D.Y., Gogineni A., et al. Influences of aortic motion and curvature on vessel expansion in murine experimental aneurysms. Arterioscler Thromb Vasc Biol 2011, 31(2). 270-U102.
21. Haskett D., Speicher E., Fouts M., Larson D., Azhar M., Utzinger U., et al. The effects of angiotensin ii on the coupled microstructural and biomechanical response of c57bl/6 mouse aorta. J Biomech 2012, 45(5):772-779.
22. Luo J., Fujikura K., Tyrie L.S., Tilson M., David I., Konofagou E.E. Pulse wave imaging of normal and aneurysmal abdominal aortas invivo. IEEE Trans Med Imaging 2009, 28(4):477-486.
23. Trachet B., Bols J., De Santis G., Vandenberghe S., Loeys B., Segers P. The impact of simplified boundary conditions and aortic arch inclusion on cfd simulations in the mouse aorta: a comparison with mouse-specific reference data. J Biomech Eng - Trans ASME 2011, 133:121006-121011.
24. Amirbekian S., Long R.C., Consolini M.A., Suo J., Willett N.J., Fielden S.W., et al. Invivo assessment of blood flow patterns in abdominal aorta of mice with mri: implications for aaa localization. Am J Physiol-Heart Circul Physiol 2009, 297(4):H1290-H1295.
25. Ford M.D., Black A.T., Cao R.Y., Funk C.D., Piomelli U. Hemodynamics of the mouse abdominal aortic aneurysm. J Biomech Eng-Trans ASME 2011, 133(12).
26. Trachet B., Renard M., De Santis G., Staelens S., De Backer J., Antiga L., et al. An integrated framework to quantitatively link mouse-specific hemodynamics to aneurysm formation in angiotensin ii-infused apoe -/- mice. Ann Biomed Eng 2011, 39(9):2430-2444.
27. Klima T., Spjut H.J., Coelho A., Gray A.G., Wukasch D.C., Reul G.J.J., et al. The morphology of ascending aortic aneurysms. Hum Pathol 1983, 14(9):810-817.
28. Kirsch E.W., Radu N.C., Allaire E., Loisance D.Y. Pathobiology of idiopathic ascending aortic aneurysms. Asian Cardiovasc Thorac Ann 2006, 14(3):254-260.
29. Sakalihasan N., Van Damme H., Gomez P., Rigo P., Lapiere C.M., Nusgens B., et al. Positron emission tomography (pet) evaluation of abdominal aortic aneurysm (aaa). Eur J Vasc Endovasc Surg May 2002, 23(5):431-436.
30. Reeps C., Essler M., Pelisek J., Seidl S., Eckstein H., Krause B. Increased 18f-fluorodeoxyglucose uptake in abdominal aortic aneurysms in positron emission/computed tomography is associated with inflammation, aortic wall instability, and acute symptoms. J Vasc Surg Aug 2008, 48(2):417-423. [discussion 424].
31. Courtois A., Nusgens B.V., Hustinx R., Namur G., Gomez P., Somja J., et al. F-18-fdg uptake assessed by pet/ct in abdominal aortic aneurysms is associated with cellular and molecular alterations prefacing wall deterioration and rupture. J Nucl Med 2013, 54(10):1740-1747.